AI assistant
Sending…
MESA LABORATORIES INC /CO/ — Director's Dealing 2021
Jun 16, 2021
33153_dirs_2021-06-16_d7b27a1c-6e01-4cd2-a947-20c53343d9c8.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: MESA LABORATORIES INC /CO/ (MLAB)
CIK: 0000724004
Period of Report: 2021-06-15
Reporting Person: Owens Gary M (Director, President and CEO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-06-15 | Common Stock | M | 1000 | — | Acquired | 9513 | Direct |
| 2021-06-15 | Common Stock | M | 706 | — | Acquired | 10219 | Direct |
| 2021-06-15 | Common Stock | M | 1831 | — | Acquired | 12050 | Direct |
| 2021-06-15 | Common Stock | F | 1557 | $263.3 | Disposed | 10493 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-06-15 | Restricted Stock Unit - 2 | $ | M | 1000 | Disposed | Common Stock (1000) | Direct | |
| 2021-06-15 | Restricted Stock Units - 3 | $ | M | 706 | Disposed | Common Stock (706) | Direct | |
| 2021-06-15 | Restricted Stock Unit - 4 | $ | M | 1831 | Disposed | Common Stock (1831) | Direct |
Footnotes
F1: Each RSU represents a contingent right to receive one share of the Issuer's common stock
F2: RSUs that vest 1/5 on June 15, 2020 and each of the next four anniversary dates
F3: Not Applicable
F4: RSUs that vest 1/3 on June 15, 2021 and each of the next two anniversary dates
F5: RSUs granted for 15% salary reduction for the twelve months ended May 31, 2021 and 60% of cash bonus target for Fiscal Year 2021
More from MESA LABORATORIES INC /CO/
Major Shareholding Notification
2026
Apr 15
Major Shareholding Notification
2026
Mar 27
Regulatory Filings
2026
Mar 23
Major Shareholding Notification
2026
Mar 13
Regulatory Filings
2026
Mar 9
Regulatory Filings
2026
Feb 3
Interim / Quarterly Report
2026
Feb 3
Director's Dealing
2025
Dec 5
Interim / Quarterly Report
2025
Nov 6
Regulatory Filings
2025
Nov 6